CA2213638C — Aerosols containing nanoparticle dispersions
Assigned to Alkermes Pharma Ireland Ltd · Expires 2004-05-04 · 22y expired
What this patent protects
There is disclosed an aerosol comprising droplets of an aqueous dispersion o f nanoparticles, said nanoparticles comprising insoluble therapeutic or diagnostic agent particles having a surface modifier on the surface thereof. There is also disclosed a method for making the aeroso…
USPTO Abstract
There is disclosed an aerosol comprising droplets of an aqueous dispersion o f nanoparticles, said nanoparticles comprising insoluble therapeutic or diagnostic agent particles having a surface modifier on the surface thereof. There is also disclosed a method for making the aerosol and methods for treatment and diagnosis using the aerosol.
Drugs covered by this patent
- Ztalmy (GANAXOLONE) · Marinus
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.